Inactive Instrument

News Caribbean International Holdings Inc Other OTC

Equities

US1418201000

End-of-day quote Other OTC Other stock markets
- ^USD	-

05-14	Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M	MT
2023	NovaBay to Commercialize BioStem's Amniotic Tissue Allograft	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments	01:15pm	NE
BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM)	01:02pm	AQ
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM)	09:34am	AQ
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers	07-10	AQ
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study	06-26	AQ
UPDATE -- PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion	06-17	AQ
BioStem Technologies to Sponsor MRO Better Half Dash	05-29	AQ
4 Stocks to Watch in the Booming Regenerative Medicine Market	05-20	AQ
Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M	05-14	MT
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million	05-14	AQ
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024	05-07	AQ
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent	05-06	AQ
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts	04-30	AQ
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase	04-25	AQ
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange	04-24	AQ
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference	04-02	AQ
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase	04-01	AQ
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024	03-21	AQ
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market	02-26	AQ
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies	01-30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Caribbean International Holdings Inc Other OTC

Equities

US1418201000

Summary

Filters